AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to AtriCure’s First Quarter 2024 Earnings Conference Call. This call is being recorded for replay purposes.
Atricure Inc. (ATRC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Entropy Technologies Vikram Modi And Arjun Modi | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $76.68 | 34 | Director | 16,228 | 2021-04-30 | Filing | |
| $40.54 | 12,350 | Director | 41,036 | 2020-11-17 | Filing | |
| $24.86 | 500 | Director | 25,670 | 2019-09-12 | Filing | |
| $17.64 | 11,000 | Director | 16,805 | 2018-03-01 | Filing | |
| $17.43 | 1,000 | Director | 10,469 | 2018-03-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.09 | 1,500 | Officer | 71,284 | 2024-05-01 | Filing | |
| $30.39 | 1,500 | Officer | 72,784 | 2024-04-01 | Filing | |
| $32.16 | 1,885 | Officer | 50,954 | 2024-03-18 | Filing | |
| $36.72 | 1,500 | Officer | 74,284 | 2024-03-12 | Filing | |
| $37.36 | 8,231 | Officer | 52,839 | 2024-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,766,029 | $170,099,574 | 0% | |
| 2. | 4,193,887 | $149,679,814 | 0% | |
| 3. | 3,394,036 | $121,133,145 | 0.04% | |
| 4. | 2,105,395 | $75,141,548 | 0.44% | |
| 5. | 1,449,726 | $51,741,000 | 0.05% |
News See All
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
AtriCure (ATRC) Fell on Competitor Action
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript
AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.22. AtriCure, Inc.
AtriCure, Inc. (NASDAQ:ATRC) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure’s Third Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
AtriCure, Inc. (NASDAQ:ATRC) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure's Second Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
AtriCure, Inc. (NASDAQ:ATRC) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure's First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
12 Most Promising Medical Stocks According to Analysts
Regardless of the short-term market situation, the healthcare industry has a huge growth potential.
AtriCure, Inc. (NASDAQ:ATRC) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to AtriCure's Q4 2022 Earnings Conference Call. My name is Amy, and I will be your coordinator for the call today.
Alger Capital Believes that AtriCure (ATRC) is Well-Positioned in the Atrial Fibrillation Market
Alger Capital, an investment management company, released its “Alger Small Cap Focus Fund” second quarter investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
